Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.8358465126056116e-12,7.665531968876861,199.72516655894682,"['RPL41', 'RPL3', 'RPS7', 'RPL34', 'RPLP1', 'RPL35A', 'RPSA', 'RPL10A', 'RPL9', 'RPS15', 'RPS26', 'RPL7A', 'RPS15A', 'RPS27', 'RPL18A', 'RPS18', 'RPL38', 'RPL26', 'RPL15', 'FAU', 'RPS27A', 'RPS10', 'RPS21']",1.9246669120170334e-09,0,0,23
2,Platelet-mediated interactions with vascular and circulating cells WP4462,1.9546161253747725e-06,18.333278145695363,240.99674809144568,"['SELP', 'VCAM1', 'IL1B', 'CCL2', 'SELE', 'TLR4', 'TLR2']",0.00038896860894957973,0,0,7
3,Spinal Cord Injury WP2431,8.784613929064724e-05,3.5111557340473003,32.79392662287839,"['EGR1', 'BDNF', 'CXCL1', 'PDYN', 'TNFSF13B', 'SELP', 'NR4A1', 'ZFP36', 'VCAN', 'FCGR2A', 'IL1B', 'LEP', 'CCL2', 'LTB', 'TLR4']",0.011654254479225867,0,0,15
4,"GPCRs, Class A Rhodopsin-like WP455",0.00032234260887517655,2.7305639359480156,21.95344890684315,"['GPR65', 'OPRL1', 'GPR4', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'HCRTR2', 'HCRTR1', 'MC4R', 'MAS1', 'OPN1SW', 'CYSLTR2', 'GPR171', 'RHO', 'ACKR4', 'OR7C1', 'GPR18']",0.03207308958308007,0,0,18
5,Kynurenine Pathway and links to Cellular Senescence WP5044,0.0013698395546682476,7.460369881109643,49.18667862794666,"['CDKN1A', 'IL1R2', 'KMO', 'TLR4', 'ACMSD']",0.1033723891515021,0,0,5
6,Selenium Micronutrient Network WP15,0.0017817882331678705,3.3274231678487,21.063047150103554,"['SERPINA3', 'SELENOM', 'IL1B', 'SELENOW', 'DIO3', 'CCL2', 'KMO', 'SEPHS2', 'XDH', 'SELENOH']",0.1033723891515021,0,0,10
7,Nonalcoholic fatty liver disease WP4396,0.0018251786477813672,2.542913589843244,16.035809938245176,"['VCAM1', 'NDUFB11', 'NDUFA4', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'SOCS3', 'UQCRQ', 'IL1B', 'LEP', 'LEPR', 'CYCS', 'CCL2']",0.1033723891515021,0,0,15
8,Pre-implantation embryo WP3527,0.002077836967869389,4.437407184427052,27.407325296399033,"['EGR1', 'ZFP36', 'FOXD1', 'GATA2', 'KLF4', 'AQP3', 'TBX3']",0.1033723891515021,0,0,7
9,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.0024896117223936055,2.9574072177267916,17.731515046389447,"['UQCRQ', 'NDUFA4', 'UCP1', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX7A1', 'COX7C', 'ATP5MC1']",0.10842297066769137,0,0,11
10,Nanomaterial-induced inflammasome activation WP3890,0.0029402122356460563,15.635375494071146,91.14288020590794,"['IL1B', 'CASP1', 'TLR4']",0.10842297066769137,0,0,3
11,Mitochondrial CIV Assembly WP4922,0.0029966147671975003,4.823260073260073,28.0244531375129,"['PET100', 'NDUFA4', 'SCO2', 'COX7A2', 'COX14', 'COX7C']",0.10842297066769137,0,0,6
12,Cori Cycle WP1946,0.004016763777244588,7.587431038618374,41.861971893045556,"['LDHA', 'TPI1', 'PGAM1', 'ALDOA']",0.12297476794948815,0,0,4
13,Galanin receptor pathway WP4970,0.004016763777244588,7.587431038618374,41.861971893045556,"['YAP1', 'POMC', 'CDKN1A', 'UCP1']",0.12297476794948815,0,0,4
14,Genes controlling nephrogenesis WP4823,0.004776458647982001,4.323481116584565,23.104924664477732,"['FOXC1', 'FOXD1', 'EYA1', 'LAMB2', 'GLI3', 'PAX2']",0.13578789584977402,0,0,6
15,Apoptosis Modulation and Signaling WP1772,0.005963447849865685,2.7559840425531914,14.116443686954716,"['BCL2A1', 'BAG3', 'IL1R2', 'CASP4', 'CASP1', 'TNFRSF10C', 'PMAIP1', 'CYCS', 'TNFRSF1B', 'TNFRSF10D']",0.1582301496164362,0,0,10
16,Mesodermal commitment pathway WP2857,0.006396689413574127,2.3507550296947652,11.875954939631207,"['YAP1', 'FOXC1', 'LEF1', 'ZIC5', 'TBX6', 'SMAD6', 'KLF4', 'DKK1', 'TBX3', 'ZIC2', 'ZIC3', 'RPL38', 'TEAD2']",0.15911764916265642,0,0,13
17,White fat cell differentiation WP4149,0.009573980012561224,4.349130339057684,20.21782950098429,"['EGR2', 'MECOM', 'EBF1', 'GATA2', 'KLF4']",0.2179505352625934,0,0,5
18,GDNF/RET signaling axis WP4830,0.00985705938373538,5.562708883025506,25.697308566060485,"['FOXC1', 'EYA1', 'PAX2', 'GLI3']",0.2179505352625934,0,0,4
19,Glycolysis and Gluconeogenesis WP534,0.010489495766904975,3.580952380952381,16.319764076820267,"['LDHC', 'LDHA', 'TPI1', 'PGAM1', 'ALDOB', 'ALDOA']",0.21972733238043052,0,0,6
20,Role of Osx and miRNAs in tooth development WP3971,0.01207623953028057,7.815711462450593,34.518210286759306,"['NOTCH3', 'KLF4', 'DKK1']",0.23709652229461228,0,0,3
21,Prader-Willi and Angelman Syndrome WP3998,0.012510118010519744,3.0478200883002207,13.353162772487387,"['POMC', 'PCSK1', 'MAGEL2', 'BDNF', 'ATP10A', 'CGA', 'TYR']",0.23709652229461228,0,0,7
22,Computational Model of Aerobic Glycolysis WP4629,0.015559598063832825,6.946859903381642,28.92031679810583,"['LDHA', 'TPI1', 'ALDOA']",0.2580300012252277,0,0,3
23,EDA signaling in hair follicle development WP3930,0.015559598063832825,6.946859903381642,28.92031679810583,"['SOSTDC1', 'LTB', 'DKK1']",0.2580300012252277,0,0,3
24,LTF danger signal response pathway WP4478,0.015559598063832825,6.946859903381642,28.92031679810583,"['IL1B', 'TLR4', 'TLR2']",0.2580300012252277,0,0,3
25,Hematopoietic Stem Cell Differentiation WP2849,0.019888697167889317,3.0557491289198606,11.971214063560014,"['IL1B', 'LEF1', 'GATA2', 'CD34', 'FLI1', 'RUNX1']",0.31662805891279794,0,0,6
26,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.026040266898218468,3.260196499339498,11.893559403041955,"['CASP5', 'IL1B', 'CASP1', 'NLRC4', 'NOD2']",0.3538808332743081,0,0,5
27,FTO Obesity Variant Mechanism WP3407,0.027941090582262296,10.409868421052632,37.242937510827794,"['PRDM16', 'UCP1']",0.3538808332743081,0,0,2
28,let-7 inhibition of ES cell reprogramming WP3299,0.027941090582262296,10.409868421052632,37.242937510827794,"['EGR1', 'KLF4']",0.3538808332743081,0,0,2
29,Thyroxine (Thyroid Hormone) Production WP1981,0.027941090582262296,10.409868421052632,37.242937510827794,"['TRH', 'CGA']",0.3538808332743081,0,0,2
30,Proximal tubule transport WP4917,0.028628011798852143,2.78342151675485,9.890525421001009,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC22A8', 'ABCG2', 'ATP6V1B1']",0.3538808332743081,0,0,6
31,Leptin Insulin Overlap WP3935,0.029053637742824476,5.209156785243742,18.433182522397427,"['SOCS3', 'LEP', 'LEPR']",0.3538808332743081,0,0,3
32,Mitochondrial complex III assembly WP4921,0.029053637742824476,5.209156785243742,18.433182522397427,"['UQCRQ', 'UQCR11', 'UQCR10']",0.3538808332743081,0,0,3
33,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.029524841058752745,3.7910769968817464,13.354157054330253,"['EGR2', 'RAB3A', 'RAB25', 'NEFL']",0.3538808332743081,0,0,4
34,Complement system WP2806,0.03023102595810672,2.3216917182434424,8.123335885248103,"['SELP', 'FKBP2', 'CD93', 'CFH', 'CFI', 'ICAM2', 'SELE', 'TLR2']",0.3538808332743081,0,0,8
35,Adipogenesis WP236,0.03326291413905045,2.0500886524822697,6.977091705933583,"['SOCS3', 'EGR2', 'CDKN1A', 'CYP26B1', 'GADD45B', 'LEP', 'EBF1', 'UCP1', 'GATA2', 'PRLR']",0.3696865519018361,0,0,10
36,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.033438984594135926,3.626018125501893,12.32132872775748,"['VCAM1', 'BCL2A1', 'IL1B', 'SELE']",0.3696865519018361,0,0,4
37,Serotonin and anxiety WP3947,0.03456679934444436,4.808148373365765,16.178753896466972,"['POMC', 'ARC', 'CRH']",0.3718266524078068,0,0,3
38,Ovarian infertility WP34,0.037640864487076764,3.4747141600703606,11.39589840635111,"['EGR1', 'GJA4', 'PGR', 'PRLR']",0.3775175656576494,0,0,4
39,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.037941463885190894,8.32736842105263,27.244740624170703,"['IL1B', 'CASP1']",0.3775175656576494,0,0,2
40,COVID-19 adverse outcome pathway WP4891,0.037941463885190894,8.32736842105263,27.244740624170703,"['IL1B', 'CCL2']",0.3775175656576494,0,0,2
41,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.04057899951850313,4.4644268774703555,14.306276462694518,"['TLR5', 'TLR4', 'TLR2']",0.3939132148381523,0,0,3
42,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.04907383577479693,6.939035087719298,20.917230421850178,"['TLR4', 'TLR2']",0.44389515087202674,0,0,2
43,Dual hijack model of Vif in HIV infection WP3300,0.04907383577479693,6.939035087719298,20.917230421850178,"['ELOB', 'RUNX1']",0.44389515087202674,0,0,2
44,HIF1A and PPARG regulation of glycolysis WP2456,0.04907383577479693,6.939035087719298,20.917230421850178,"['LDHA', 'TPI1']",0.44389515087202674,0,0,2
45,Vitamin D Receptor Pathway WP2877,0.05090320935168864,1.8251960349164078,5.435122240723046,"['IL1RL1', 'CDKN1A', 'CEACAM1', 'COL13A1', 'CASP5', 'PNOC', 'HILPDA', 'SOSTDC1', 'KLF4', 'CYP3A5', 'S100A8']",0.4497290354948436,0,0,11
46,Heart Development WP1591,0.05197873274563519,3.088048470634223,9.131114228390594,"['FOXC1', 'NFATC1', 'TBX2', 'FGF10']",0.4497290354948436,0,0,4
47,Irinotecan pathway WP229,0.06121339845495127,5.947368421052632,16.613314623146376,"['CYP3A5', 'ABCG2']",0.49955872725956746,0,0,2
48,Leptin and adiponectin WP3934,0.06121339845495127,5.947368421052632,16.613314623146376,"['LEP', 'LEPR']",0.49955872725956746,0,0,2
49,Imatinib and Chronic Myeloid Leukemia WP3640,0.0615034613962784,3.675889328063241,10.250812234328334,"['SPRED2', 'FLT1', 'ABCG2']",0.49955872725956746,0,0,3
50,Netrin-UNC5B signaling pathway WP4747,0.06331390558729105,2.4823866138265083,6.850518954708219,"['YAP1', 'CDH5', 'VCAM1', 'CCL2', 'SELE']",0.5039786884748367,0,0,5
51,Differentiation of white and brown adipocyte WP2895,0.06939489816059191,3.471453667105841,9.261636788566566,"['LEP', 'PRDM16', 'EBF3']",0.5211164050550109,0,0,3
52,IL1 and megakaryocytes in obesity WP2865,0.06939489816059191,3.471453667105841,9.261636788566566,"['IL1B', 'CCL2', 'TLR2']",0.5211164050550109,0,0,3
53,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.06939489816059191,3.471453667105841,9.261636788566566,"['IL4R', 'CCL2', 'TLR4']",0.5211164050550109,0,0,3
54,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.07424439577283898,5.2036184210526315,13.531452822875998,"['SOCS3', 'CHI3L1']",0.5472086947701835,0,0,2
55,Inflammatory Response Pathway WP453,0.07771744349451126,3.2885375494071147,8.401146468799386,"['IL4R', 'LAMB2', 'TNFRSF1B']",0.5569147044319779,0,0,3
56,Peptide GPCRs WP24,0.07835985791002704,2.316453838250404,5.898718817620509,"['MC4R', 'OPRL1', 'SSTR1', 'HCRTR2', 'HCRTR1']",0.5569147044319779,0,0,5
57,Regulation of toll-like receptor signaling pathway WP1449,0.0824916583219887,1.7726452679846652,4.422852937861018,"['CISH', 'IL1B', 'PELI3', 'CD180', 'IRAK3', 'SMAD6', 'TLR5', 'TLR4', 'TLR2']",0.5736508705109601,0,0,9
58,Oxidative phosphorylation WP623,0.08376549693814118,2.2659525587272413,5.618959800141856,"['ATP6AP1', 'NDUFA4', 'ATP6AP2', 'ATP5MC3', 'ATP5MC1']",0.5736508705109601,0,0,5
59,Pathways in clear cell renal cell carcinoma WP4018,0.08668263578302089,1.921523178807947,4.699088189937042,"['LDHC', 'LDHA', 'FLT1', 'TPI1', 'ALDOB', 'ALDOA', 'ACACB']",0.5736508705109601,0,0,7
60,Serotonin Transporter Activity WP1455,0.08805955674356485,4.625146198830409,11.23791156953651,"['IL1B', 'TGFB1I1']",0.5736508705109601,0,0,2
61,Complement and Coagulation Cascades WP558,0.08936269842130534,2.217600269822086,5.355619806019683,"['VWF', 'CFH', 'SERPIND1', 'CFI', 'TFPI']",0.5736508705109601,0,0,5
62,Phosphodiesterases in neuronal function WP4222,0.08936269842130534,2.217600269822086,5.355619806019683,"['ADCY10', 'PDE10A', 'ADCY4', 'PDE6C', 'PDE5A']",0.5736508705109601,0,0,5
63,Vitamin B12 metabolism WP1533,0.09525456756189335,2.451187335092348,5.76323733117751,"['SERPINA3', 'TCN1', 'IL1B', 'CCL2']",0.5749113473154354,0,0,4
64,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.09549968172434513,1.8720156223467481,4.396676476988443,"['MC4R', 'POMC', 'NHSL1', 'PRDM16', 'UCP1', 'DIO3', 'TRH']",0.5749113473154354,0,0,7
65,VEGFA-VEGFR2 Signaling Pathway WP3888,0.09950376287952628,1.34621354549989,3.106468283568969,"['FLT1', 'GATA2', 'RPL10A', 'ACACB', 'FUT1', 'APOLD1', 'ACTG1', 'CDH5', 'LDHA', 'RPL18A', 'CCL2', 'DNAJB9', 'TMSB10', 'CGNL1', 'EGR1', 'EGR3', 'TNFRSF10C', 'NFATC1', 'DKK1', 'SELE', 'NR4A1', 'NR4A3', 'CYCS', 'RPL26', 'ALDOA']",0.5749113473154354,0,0,25
66,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.09963902491585205,1.6439102027140224,3.7911879693945627,"['ADCYAP1', 'EGR1', 'BDNF', 'SST', 'IL1B', 'SSTR1', 'GATA2', 'TAC1', 'ALDOA', 'YWHAH']",0.5749113473154354,0,0,10
67,ACE Inhibitor Pathway WP554,0.1025595619582812,4.162368421052632,9.479009709324194,"['MAS1', 'ATP6AP2']",0.5749113473154354,0,0,2
68,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.1025595619582812,4.162368421052632,9.479009709324194,"['SST', 'DKK1']",0.5749113473154354,0,0,2
69,Serotonin and anxiety-related events WP3944,0.1025595619582812,4.162368421052632,9.479009709324194,"['ARC', 'CRH']",0.5749113473154354,0,0,2
70,Sulfation Biotransformation Reaction WP692,0.1025595619582812,4.162368421052632,9.479009709324194,"['SULT1B1', 'SULT4A1']",0.5749113473154354,0,0,2
71,Transcriptional cascade regulating adipogenesis WP4211,0.1025595619582812,4.162368421052632,9.479009709324194,"['EGR2', 'GATA2']",0.5749113473154354,0,0,2
72,Canonical and non-canonical Notch signaling WP3845,0.10508439005287533,2.8395616241466044,6.397508307541083,"['NOTCH3', 'MAML2', 'LEF1']",0.5808831561256164,0,0,3
73,Development of ureteric collection system WP5053,0.11769023208350422,2.2520145475290594,4.818633856588472,"['FOXC1', 'GLI3', 'PAX2', 'GLI2']",0.6276646813025458,0,0,4
74,Leptin signaling pathway WP2034,0.12407316269720513,1.8392857142857142,3.838375681407925,"['SOCS3', 'CISH', 'IL1B', 'LEP', 'LEPR', 'ACACB']",0.6276646813025458,0,0,6
75,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.12512762076918874,2.6026021080368906,5.409303126769152,"['IL1B', 'CXCL1', 'GLI2']",0.6276646813025458,0,0,3
76,Hepatitis C and Hepatocellular Carcinoma WP3646,0.1256354014993566,2.192612137203166,4.548291482444761,"['CDKN1A', 'MYOF', 'LEF1', 'CD44']",0.6276646813025458,0,0,4
77,Cells and molecules involved in local acute inflammatory response  WP4493,0.1332535989121975,3.468201754385965,6.990164824092447,"['SELP', 'VCAM1']",0.6276646813025458,0,0,2
78,Cytokines and Inflammatory Response WP530,0.1332535989121975,3.468201754385965,6.990164824092447,"['IL1B', 'CXCL1']",0.6276646813025458,0,0,2
79,Hedgehog Signaling Pathway Netpath WP47,0.1332535989121975,3.468201754385965,6.990164824092447,"['GLI3', 'GLI2']",0.6276646813025458,0,0,2
80,Nephrogenesis WP5052,0.1332535989121975,3.468201754385965,6.990164824092447,"['FOXD1', 'PAX2']",0.6276646813025458,0,0,2
81,Phytochemical activity on NRF2 transcriptional activation WP3,0.1332535989121975,3.468201754385965,6.990164824092447,"['HMOX1', 'SLC7A11']",0.6276646813025458,0,0,2
82,Oncostatin M Signaling Pathway WP2374,0.13364005119536487,1.9292773619061598,3.882873802088315,"['SOCS3', 'EGR1', 'PRKCH', 'CCL2', 'OSMR']",0.6276646813025458,0,0,5
83,Oxidation by Cytochrome P450 WP43,0.13379978204812082,2.136256004329883,4.296888313708978,"['CYP39A1', 'CYP26B1', 'CYP3A5', 'CYP2C18']",0.6276646813025458,0,0,4
84,Pathways Regulating Hippo Signaling WP4540,0.13545000243274088,1.6970121669490221,3.3925864427454426,"['CDH5', 'PRKCH', 'FLT1', 'CDH20', 'LEF1', 'CDH17', 'TEAD2']",0.6276646813025458,0,0,7
85,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.13562603666336417,2.4983399209486166,4.991318182363891,"['GGT5', 'CYSLTR2', 'TRPA1']",0.6276646813025458,0,0,3
86,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.13562603666336417,2.4983399209486166,4.991318182363891,"['GJB2', 'PGR', 'PRLR']",0.6276646813025458,0,0,3
87,Major receptors targeted by epinephrine and norepinephrine WP4589,0.14928437106218342,3.2012145748987852,6.088397239062107,"['ADCY10', 'ADCY4']",0.6739026876020846,0,0,2
88,Selective expression of chemokine receptors during T-cell polarization WP4494,0.14928437106218342,3.2012145748987852,6.088397239062107,"['IL4R', 'IL18R1']",0.6739026876020846,0,0,2
89,Lung fibrosis WP3624,0.1507500753684564,2.0317909775403824,3.8444166109534024,"['CYSLTR2', 'IL1B', 'HMOX1', 'CCL2']",0.6739026876020846,0,0,4
90,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.15512456156127025,1.82738881549978,3.4053881446714542,"['PRKCH', 'CCL2', 'NOD2', 'TLR4', 'TLR2']",0.6739026876020846,0,0,5
91,p53 transcriptional gene network WP4963,0.15512456156127025,1.82738881549978,3.4053881446714542,"['CDKN1A', 'CCL2', 'PMAIP1', 'SLC7A11', 'TNFRSF10D']",0.6739026876020846,0,0,5
92,Sleep regulation WP3591,0.15746972348490923,2.312984921680574,4.2756036777028,"['CRH', 'HCRTR2', 'HCRTR1']",0.6739026876020846,0,0,3
93,Toll-like Receptor Signaling related to MyD88 WP3858,0.15746972348490923,2.312984921680574,4.2756036777028,"['TLR5', 'TLR4', 'TLR2']",0.6739026876020846,0,0,3
94,Dopaminergic Neurogenesis WP2855,0.16567260310976709,2.9723684210526318,5.343550683658824,"['SLC18A2', 'GLI2']",0.7014648514647586,0,0,2
95,IL-18 signaling pathway WP4754,0.16981621045659806,1.3590846909588359,2.409709538530803,"['SLC12A3', 'NRN1', 'ACACB', 'FUT1', 'SOCS3', 'NR4A1', 'ARL4D', 'IL1B', 'HMOX1', 'CYCS', 'CCL2', 'LTB', 'IL18R1', 'TGM2']",0.7035731591666464,0,0,14
96,GABA metabolism (aka GHB) WP4157,0.17147386039991133,6.931230836618484,12.222008743791504,['PON3'],0.7035731591666464,0,0,1
97,Gastric acid production WP2596,0.17147386039991133,6.931230836618484,12.222008743791504,['VIP'],0.7035731591666464,0,0,1
98,Circadian rhythm related genes WP3594,0.1821963951057196,1.3988909096814004,2.3818496967086022,"['PER2', 'EGR1', 'MAGEL2', 'EGR3', 'LEP', 'CRH', 'OPRL1', 'CARTPT', 'RPS27A', 'HCRTR2', 'HCRTR1']",0.7185742481358349,0,0,11
99,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.18235175643648072,2.774035087719298,4.720902094667433,"['VCAM1', 'LEF1']",0.7185742481358349,0,0,2
100,Blood Clotting Cascade WP272,0.18235175643648072,2.774035087719298,4.720902094667433,"['F8A1', 'VWF']",0.7185742481358349,0,0,2
101,miR-509-3p alteration of YAP1/ECM axis WP3967,0.18235175643648072,2.774035087719298,4.720902094667433,"['YAP1', 'TEAD2']",0.7185742481358349,0,0,2
102,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.1857919602412623,1.7071269246594625,2.873312656264432,"['CDKN1A', 'LAMB2', 'DKK1', 'TLR4', 'PAX2']",0.7249529429021803,0,0,5
103,DNA damage response WP707,0.19378281877881173,1.6794860868453574,2.7560656192384436,"['CDKN1A', 'GADD45B', 'PMAIP1', 'CYCS', 'SFN']",0.7487918628540492,0,0,5
104,BMP Signaling Pathway in Eyelid Development WP3927,0.19926063672984515,2.6004934210526316,4.194964063150856,"['FOXC1', 'FGF10']",0.7552926992236035,0,0,2
105,TP53 network WP1742,0.19926063672984515,2.6004934210526316,4.194964063150856,"['CDKN1A', 'PMAIP1']",0.7552926992236035,0,0,2
106,Amyotrophic lateral sclerosis (ALS) WP2447,0.20395121275682448,2.014025245441795,3.2020473134046434,"['CASP1', 'NEFL', 'NEFM']",0.7602253775176914,0,0,3
107,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.20588505887852335,1.7717397406388593,2.800123452446229,"['BEX3', 'SOCS3', 'CDKN1A', 'YBX3']",0.7602253775176914,0,0,4
108,miR-517 relationship with ARCN1 and USP1 WP3596,0.20954055077075323,5.198094612352168,8.123779780425426,['CDKN1A'],0.7602253775176914,0,0,1
109,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.20954055077075323,5.198094612352168,8.123779780425426,['MAS1'],0.7602253775176914,0,0,1
110,miRNA regulation of DNA damage response WP1530,0.21011254152499007,1.6267957397622193,2.537983522275139,"['CDKN1A', 'GADD45B', 'PMAIP1', 'CYCS', 'SFN']",0.7602253775176914,0,0,5
111,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.21603301589285018,1.950963438735178,2.989508161991296,"['LDHA', 'BCL2A1', 'PMAIP1']",0.7657187412003308,0,0,3
112,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.216343044206663,2.4473684210526314,3.746651752725055,"['LDHA', 'ACACB']",0.7657187412003308,0,0,2
113,Myometrial relaxation and contraction pathways WP289,0.2174025571749683,1.3892872952633908,2.1200587224784466,"['RGS4', 'PRKCH', 'IL1B', 'CRH', 'ADCY4', 'SFN', 'CALM3', 'ACTG1', 'YWHAH']",0.7657187412003308,0,0,9
114,Calcium Regulation in the Cardiac Cell WP536,0.22313312336659819,1.37898406374502,2.0684577825239705,"['RGS4', 'GJB2', 'PRKCH', 'PLN', 'GJA4', 'ADCY4', 'SFN', 'CALM3', 'YWHAH']",0.7790086236833866,0,0,9
115,Cardiac Progenitor Differentiation WP2406,0.22825952724514487,1.8917235597077495,2.794590284299326,"['MESP1', 'THY1', 'DKK1']",0.7831663089962728,0,0,3
116,Tryptophan metabolism WP465,0.22825952724514487,1.8917235597077495,2.794590284299326,"['DHCR24', 'CYP2C18', 'ACMSD']",0.7831663089962728,0,0,3
117,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.23354744508450248,2.3112573099415203,3.361423366834397,"['H2AFZ', 'DUSP6']",0.787260529659405,0,0,2
118,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.23354744508450248,2.3112573099415203,3.361423366834397,"['FCGR2A', 'IL1B']",0.787260529659405,0,0,2
119,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.23538694228509846,1.5536583923184606,2.247405016157043,"['CDKN1A', 'GADD45B', 'LEF1', 'PMAIP1', 'CYCS']",0.787260529659405,0,0,5
120,Effects of nitric oxide WP1995,0.24586045384127095,4.158212877792378,5.83393592894561,['XDH'],0.7930881074881769,0,0,1
121,Hfe effect on hepcidin production WP3924,0.24586045384127095,4.158212877792378,5.83393592894561,['HAMP'],0.7930881074881769,0,0,1
122,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.24586045384127095,4.158212877792378,5.83393592894561,['CDKN1A'],0.7930881074881769,0,0,1
123,Metapathway biotransformation Phase I and II WP702,0.2481277111234442,1.3658303256946558,1.9037102897500398,"['CYP39A1', 'SULT1B1', 'CYP26B1', 'GLYAT', 'GAL3ST2', 'CYP2C18', 'SULT4A1', 'CYP3A5']",0.7930881074881769,0,0,8
124,Globo Sphingolipid Metabolism WP1424,0.25082666235608175,2.1894736842105265,3.0280271437991217,"['A4GALT', 'FUT1']",0.7930881074881769,0,0,2
125,Acute viral myocarditis WP4298,0.2526853651080365,1.5084333658798077,2.0750162945000135,"['CASP1', 'CYCS', 'NOD2', 'TLR5', 'TLR4']",0.7930881074881769,0,0,5
126,Differentiation Pathway WP2848,0.25307082826884036,1.783399209486166,2.4505436646723604,"['FST', 'DKK1', 'FGF10']",0.7930881074881769,0,0,3
127,Oxidative Damage WP3941,0.25307082826884036,1.783399209486166,2.4505436646723604,"['CDKN1A', 'CYCS', 'TNFRSF1B']",0.7930881074881769,0,0,3
128,Hedgehog Signaling Pathway WP4249,0.2656190859288396,1.7337505489679403,2.2984192401998587,"['EVC2', 'GLI3', 'GLI2']",0.7944438906115412,0,0,3
129,NRF2-ARE regulation WP4357,0.2681375850946886,2.0798684210526317,2.7376373187550707,"['HMOX1', 'SLC7A11']",0.7944438906115412,0,0,2
130,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.2681375850946886,2.0798684210526317,2.7376373187550707,"['HMOX1', 'ABCG2']",0.7944438906115412,0,0,2
131,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2681375850946886,2.0798684210526317,2.7376373187550707,"['BCL2A1', 'BCL2L14']",0.7944438906115412,0,0,2
132,Apoptosis WP254,0.27028574859146576,1.4657562282546002,1.9176130378867027,"['CASP4', 'CASP1', 'PMAIP1', 'CYCS', 'TNFRSF1B']",0.7944438906115412,0,0,5
133,Nephrotic syndrome WP4758,0.27823904533346516,1.6867855998290782,2.157862073824025,"['LAMB2', 'EMP2', 'PAX2']",0.7944438906115412,0,0,3
134,Vitamin A and carotenoid metabolism WP716,0.27823904533346516,1.6867855998290782,2.157862073824025,"['CYP26B1', 'RBP2', 'NPC1L1']",0.7944438906115412,0,0,3
135,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.2805136239838949,3.464958388085852,4.4044228982158655,['DHCR24'],0.7944438906115412,0,0,1
136,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2805136239838949,3.464958388085852,4.4044228982158655,['VIP'],0.7944438906115412,0,0,1
137,LDLRAD4 and what we know about it WP4904,0.2805136239838949,3.464958388085852,4.4044228982158655,['NEDD4'],0.7944438906115412,0,0,1
138,Molybdenum cofactor (Moco) biosynthesis WP4507,0.2805136239838949,3.464958388085852,4.4044228982158655,['XDH'],0.7944438906115412,0,0,1
139,"Phase I biotransformations, non P450 WP136",0.2805136239838949,3.464958388085852,4.4044228982158655,['PON3'],0.7944438906115412,0,0,1
140,Hepatitis B infection WP4666,0.28091502913961963,1.3116397585580317,1.6653929924725799,"['EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'CYCS', 'NFATC1', 'TLR4', 'TLR2']",0.7944438906115412,0,0,8
141,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.28544089537047834,1.9807017543859649,2.483245983433293,"['BDNF', 'CGA']",0.7944438906115412,0,0,2
142,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.28544089537047834,1.9807017543859649,2.483245983433293,"['SCO2', 'IL1B']",0.7944438906115412,0,0,2
143,Zinc homeostasis WP3529,0.28544089537047834,1.9807017543859649,2.483245983433293,"['SLC30A2', 'SLC39A12']",0.7944438906115412,0,0,2
144,Ebola Virus Pathway on Host WP4217,0.2989383149591336,1.3127140385418532,1.585125871558236,"['SOCS3', 'HLA-DRB5', 'SCIN', 'NEDD4', 'ICAM2', 'TLR4', 'ACTG1']",0.8165122868195102,0,0,7
145,TLR4 Signaling and Tolerance WP3851,0.30270081143909316,1.8905502392344498,2.2592271641205626,"['IRAK3', 'TLR4']",0.8165122868195102,0,0,2
146,Unfolded protein response WP4925,0.30270081143909316,1.8905502392344498,2.2592271641205626,"['IL1B', 'PMAIP1']",0.8165122868195102,0,0,2
147,Metabolic reprogramming in colon cancer WP4290,0.3036276845459485,1.600081078341948,1.9072215216553705,"['LDHA', 'PGAM1', 'ALDOB']",0.8165122868195102,0,0,3
148,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3036276845459485,1.600081078341948,1.9072215216553705,"['IL1B', 'NEFL', 'CYCS']",0.8165122868195102,0,0,3
149,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3135764516988961,2.9697766097240472,3.444085819803985,['ELOB'],0.821381734876252,0,0,1
150,Mitochondrial CII Assembly WP4920,0.3135764516988961,2.9697766097240472,3.444085819803985,['SDHAF1'],0.821381734876252,0,0,1
151,NAD Biosynthesis II (from tryptophan) WP2485,0.3135764516988961,2.9697766097240472,3.444085819803985,['KMO'],0.821381734876252,0,0,1
152,AMP-activated protein kinase (AMPK) signaling WP1403,0.31780205590680555,1.4347193158038396,1.6446568517046838,"['CDKN1A', 'LEP', 'LEPR', 'ACACB']",0.821381734876252,0,0,4
153,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.31780205590680555,1.4347193158038396,1.6446568517046838,"['CDKN1A', 'NEFL', 'NEFM', 'PFN2']",0.821381734876252,0,0,4
154,22q11.2 copy number variation syndrome WP4657,0.3192978779735664,1.3142857142857143,1.5004290844880237,"['CLDN5', 'CYP26B1', 'FOXC1', 'VWF', 'SERPIND1', 'FGF10']",0.821381734876252,0,0,6
155,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.3198848464970328,1.8082379862700229,2.0610191737591457,"['LEF1', 'DKK1']",0.821381734876252,0,0,2
156,Glucocorticoid Receptor Pathway WP2880,0.3283252004466225,1.4103125978265731,1.5707366388147967,"['ZIC2', 'GADD45B', 'CAVIN2', 'CCL2']",0.8274607752322215,0,0,4
157,Endoderm differentiation WP2853,0.3435675146721057,1.2449199071715629,1.330037119618441,"['DUSP4', 'DUSP2', 'ZIC3', 'LEF1', 'ZIC5', 'DKK1', 'GLI2']",0.8274607752322215,0,0,7
158,Biotin Metabolism (including IEMs) WP5031,0.34512183087575066,2.598390275952694,2.764317739947744,['ACACB'],0.8274607752322215,0,0,1
159,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.34512183087575066,2.598390275952694,2.764317739947744,['CYP2C18'],0.8274607752322215,0,0,1
160,Estrogen Receptor Pathway WP2881,0.34512183087575066,2.598390275952694,2.764317739947744,['PDK4'],0.8274607752322215,0,0,1
161,Fatty Acid Omega Oxidation WP206,0.34512183087575066,2.598390275952694,2.764317739947744,['ADH1B'],0.8274607752322215,0,0,1
162,Macrophage markers WP4146,0.34512183087575066,2.598390275952694,2.764317739947744,['CD163'],0.8274607752322215,0,0,1
163,PTF1A related regulatory pathway WP4147,0.34512183087575066,2.598390275952694,2.764317739947744,['FGF10'],0.8274607752322215,0,0,1
164,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.34512183087575066,2.598390275952694,2.764317739947744,['TBX6'],0.8274607752322215,0,0,1
165,Tgif disruption of Shh signaling WP3674,0.34512183087575066,2.598390275952694,2.764317739947744,['GLI3'],0.8274607752322215,0,0,1
166,Vitamin B12 Disorders WP4271,0.34512183087575066,2.598390275952694,2.764317739947744,['TCN1'],0.8274607752322215,0,0,1
167,Monoamine Transport WP727,0.35391045636306223,1.6633684210526316,1.7277596514790303,"['TGFB1I1', 'IL1B']",0.8350260088178585,0,0,2
168,Striated Muscle Contraction Pathway WP383,0.35391045636306223,1.6633684210526316,1.7277596514790303,"['MYL9', 'ACTG1']",0.8350260088178585,0,0,2
169,Folate Metabolism WP176,0.3545713454528093,1.4508686460152587,1.5043269120875506,"['SERPINA3', 'IL1B', 'CCL2']",0.8350260088178585,0,0,3
170,Oxidative Stress WP408,0.3707015620361188,1.5992914979757085,1.5870696405192672,"['HMOX1', 'XDH']",0.8437134963020805,0,0,2
171,Signal transduction through IL1R WP4496,0.3707015620361188,1.5992914979757085,1.5870696405192672,"['IL1B', 'IRAK3']",0.8437134963020805,0,0,2
172,Dopamine metabolism WP2436,0.37521931870720665,2.3095342385749746,2.263908406024071,['TYR'],0.8437134963020805,0,0,1
173,Gene regulatory network modelling somitogenesis  WP2854,0.37521931870720665,2.3095342385749746,2.263908406024071,['TBX6'],0.8437134963020805,0,0,1
174,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.37521931870720665,2.3095342385749746,2.263908406024071,['HMOX1'],0.8437134963020805,0,0,1
175,Neuroinflammation WP4919,0.37521931870720665,2.3095342385749746,2.263908406024071,['TLR4'],0.8437134963020805,0,0,1
176,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.37521931870720665,2.3095342385749746,2.263908406024071,['KLF4'],0.8437134963020805,0,0,1
177,Tamoxifen metabolism WP691,0.37521931870720665,2.3095342385749746,2.263908406024071,['CYP3A5'],0.8437134963020805,0,0,1
178,TGF-beta Receptor Signaling WP560,0.3799051465176326,1.3862099253403601,1.3416206419941012,"['FST', 'LEF1', 'SMAD6']",0.8494508332248188,0,0,3
179,Cell migration and invasion through p75NTR WP4561,0.38731546149586354,1.5399610136452242,1.4606773097372696,"['BDNF', 'PARD3']",0.8506150508132344,0,0,2
180,miRNAs involvement in the immune response in sepsis WP4329,0.38731546149586354,1.5399610136452242,1.4606773097372696,"['VCAM1', 'TLR4']",0.8506150508132344,0,0,2
181,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.38731546149586354,1.5399610136452242,1.4606773097372696,"['TLR4', 'TLR2']",0.8506150508132344,0,0,2
182,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3924943086798221,1.3559890015466576,1.2681659900919442,"['CXCL17', 'CCL2', 'CXCL1']",0.8506150508132344,0,0,3
183,Synaptic Vesicle Pathway WP2267,0.3924943086798221,1.3559890015466576,1.2681659900919442,"['RAB3A', 'SLC32A1', 'SLC18A2']",0.8506150508132344,0,0,3
184,Hippo-Merlin Signaling Dysregulation WP4541,0.4017586742272153,1.1883597883597883,1.0836696683174654,"['CDH5', 'FLT1', 'CDH20', 'CDH17', 'TEAD2', 'CD44']",0.8506150508132344,0,0,6
185,Base Excision Repair WP4752,0.4037330095919477,1.4848684210526315,1.3467778656516505,"['FEN1', 'POLE3']",0.8506150508132344,0,0,2
186,GABA receptor Signaling WP4159,0.4037330095919477,1.4848684210526315,1.3467778656516505,"['SLC32A1', 'GABRE']",0.8506150508132344,0,0,2
187,Type II interferon signaling (IFNG) WP619,0.4037330095919477,1.4848684210526315,1.3467778656516505,"['SOCS3', 'IL1B']",0.8506150508132344,0,0,2
188,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.4039352879489982,2.078449408672799,1.8841156198091817,['HSD11B2'],0.8506150508132344,0,0,1
189,Glycolysis in senescence WP5049,0.4039352879489982,2.078449408672799,1.8841156198091817,['LDHA'],0.8506150508132344,0,0,1
190,Pathogenic Escherichia coli infection WP2272,0.4174626317644086,1.299324769433465,1.1350384619107121,"['TLR5', 'TLR4', 'ACTG1']",0.854082402750819,0,0,3
191,Aryl Hydrocarbon Receptor Pathway WP2873,0.4199371890314367,1.4335753176043557,1.2438418089833867,"['IL1B', 'MYOF']",0.854082402750819,0,0,2
192,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.4199371890314367,1.4335753176043557,1.2438418089833867,"['CCL2', 'TLR4']",0.854082402750819,0,0,2
193,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4199371890314367,1.4335753176043557,1.2438418089833867,"['LEF1', 'GLI2']",0.854082402750819,0,0,2
194,Tumor suppressor activity of SMARCB1 WP4204,0.4199371890314367,1.4335753176043557,1.2438418089833867,"['GLI3', 'GLI2']",0.854082402750819,0,0,2
195,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4298218546689996,1.2727272727272727,1.0746711151328623,"['FST', 'LEF1', 'SMAD6']",0.854082402750819,0,0,3
196,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.4313330727460166,1.889380002389201,1.588731836522953,['SMAD6'],0.854082402750819,0,0,1
197,Iron metabolism in placenta WP2007,0.4313330727460166,1.889380002389201,1.588731836522953,['HAMP'],0.854082402750819,0,0,1
198,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4313330727460166,1.889380002389201,1.588731836522953,['PGR'],0.854082402750819,0,0,1
199,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.4313330727460166,1.889380002389201,1.588731836522953,['HLA-DRB5'],0.854082402750819,0,0,1
200,Purine metabolism WP4792,0.4313330727460166,1.889380002389201,1.588731836522953,['XDH'],0.854082402750819,0,0,1
201,RalA downstream regulated genes WP2290,0.4313330727460166,1.889380002389201,1.588731836522953,['YBX3'],0.854082402750819,0,0,1
202,BDNF-TrkB Signaling WP3676,0.4359129557916139,1.3857017543859649,1.150565762645849,"['ARC', 'BDNF']",0.858878002005259,0,0,2
203,Nuclear Receptors Meta-Pathway WP2882,0.43890473705316013,1.0770695588806323,0.8869375816648644,"['EGR1', 'GADD45B', 'CAVIN2', 'MYOF', 'SLC7A11', 'SLC39A12', 'CYP3A5', 'ZIC2', 'IL1B', 'PDK4', 'HMOX1', 'CCL2', 'FKBP5']",0.8605127357002844,0,0,13
204,CAMKK2  Pathway WP4874,0.4516470939740357,1.3409168081494058,1.06583331611164,"['VCAM1', 'HMOX1']",0.8711688837782331,0,0,2
205,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4516470939740357,1.3409168081494058,1.06583331611164,"['YAP1', 'TEAD2']",0.8711688837782331,0,0,2
206,Type 2 papillary renal cell carcinoma WP4241,0.4516470939740357,1.3409168081494058,1.06583331611164,"['CDKN1A', 'ELOB']",0.8711688837782331,0,0,2
207,Cysteine and methionine catabolism WP4504,0.4574731073106802,1.7318221638195357,1.3543493174948986,['SQOR'],0.8711688837782331,0,0,1
208,Farnesoid X receptor pathway WP2879,0.4574731073106802,1.7318221638195357,1.3543493174948986,['FKBP5'],0.8711688837782331,0,0,1
209,Ganglio Sphingolipid Metabolism WP1423,0.4574731073106802,1.7318221638195357,1.3543493174948986,['FUT1'],0.8711688837782331,0,0,1
210,Cytosolic DNA-sensing pathway WP4655,0.46629276067432485,1.1990726664639708,0.9148224190608094,"['IL1B', 'CASP1', 'POLR2K']",0.8769668674384385,0,0,3
211,IL-1 signaling pathway WP195,0.46629276067432485,1.1990726664639708,0.9148224190608094,"['IL1B', 'CCL2', 'IRAK3']",0.8769668674384385,0,0,3
212,Parkinson's disease pathway WP2371,0.4671280801430879,1.2989309210526316,0.9886836052156861,"['PINK1', 'CYCS']",0.8769668674384385,0,0,2
213,Breast cancer pathway WP4262,0.4718604496791183,1.0858060689927844,0.8155185299560985,"['NOTCH3', 'HEYL', 'CDKN1A', 'GADD45B', 'LEF1', 'PGR', 'FGF10']",0.8816922956445497,0,0,7
214,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.4824130586810042,1.5985039927221267,1.165236780589543,['PMAIP1'],0.8882122298600899,0,0,1
215,Alzheimer's disease WP2059,0.4843278274049862,1.1233687513370891,0.8144347869195042,"['ATP5MD', 'IL1B', 'CYCS', 'CALM3']",0.8882122298600899,0,0,4
216,Notch Signaling Pathway Netpath WP61,0.49002338052637795,1.1545161762553067,0.8235188980437522,"['NOTCH3', 'CDKN1A', 'MAML2']",0.8882122298600899,0,0,3
217,Nuclear receptors WP170,0.49729220939088853,1.2223684210526315,0.8539190502299067,"['NR4A1', 'PGR']",0.8882122298600899,0,0,2
218,Thermogenesis WP4321,0.5060249721522089,1.071102697844176,0.7296022308245239,"['ADCY10', 'PRDM16', 'UCP1', 'ADCY4', 'ACTG1']",0.8882122298600899,0,0,5
219,Cell Differentiation - Index expanded WP2023,0.5062079533589342,1.4842312746386335,1.010476108709724,['KLF4'],0.8882122298600899,0,0,1
220,Development and heterogeneity of the ILC family WP3893,0.5062079533589342,1.4842312746386335,1.010476108709724,['IL1B'],0.8882122298600899,0,0,1
221,ERK Pathway in Huntington's Disease WP3853,0.5062079533589342,1.4842312746386335,1.010476108709724,['BDNF'],0.8882122298600899,0,0,1
222,ID signaling pathway WP53,0.5062079533589342,1.4842312746386335,1.010476108709724,['PAX2'],0.8882122298600899,0,0,1
223,miRNAs involved in DNA damage response WP1545,0.5062079533589342,1.4842312746386335,1.010476108709724,['CDKN1A'],0.8882122298600899,0,0,1
224,Overview of nanoparticle effects WP3287,0.5062079533589342,1.4842312746386335,1.010476108709724,['HMOX1'],0.8882122298600899,0,0,1
225,Tryptophan catabolism leading to NAD+ production WP4210,0.5062079533589342,1.4842312746386335,1.010476108709724,['KMO'],0.8882122298600899,0,0,1
226,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.511959662491143,1.1873684210526316,0.7949543681288316,"['BDNF', 'GABRE']",0.8882122298600899,0,0,2
227,Neovascularisation processes WP4331,0.511959662491143,1.1873684210526316,0.7949543681288316,"['ACVRL1', 'NOTCH3']",0.8882122298600899,0,0,2
228,Proteasome Degradation WP183,0.513224969856463,1.1131422924901186,0.7425115392524527,"['PSMB6', 'H2AFZ', 'NEDD4']",0.8882122298600899,0,0,3
229,Toll-like Receptor Signaling Pathway WP75,0.5140255998656159,1.0793955384984408,0.7183185279720163,"['IL1B', 'TLR5', 'TLR4', 'TLR2']",0.8882122298600899,0,0,4
230,Corticotropin-releasing hormone signaling pathway WP2355,0.523749198889124,1.0654894797375007,0.6890971565091908,"['POMC', 'NR4A1', 'CRH', 'TLR4']",0.8882122298600899,0,0,4
231,Ferroptosis WP4313,0.5263423677594182,1.154312865497076,0.7408419087012467,"['HMOX1', 'SLC7A11']",0.8882122298600899,0,0,2
232,IL-2 signaling pathway WP49,0.5263423677594182,1.154312865497076,0.7408419087012467,"['SOCS3', 'CISH']",0.8882122298600899,0,0,2
233,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5289102976805058,1.3851949189662724,0.8822811080704044,['SYTL4'],0.8882122298600899,0,0,1
234,Glutathione metabolism WP100,0.5289102976805058,1.3851949189662724,0.8822811080704044,['GGT5'],0.8882122298600899,0,0,1
235,Hypertrophy Model WP516,0.5289102976805058,1.3851949189662724,0.8822811080704044,['NR4A3'],0.8882122298600899,0,0,1
236,Mammalian disorder of sexual development WP4842,0.5289102976805058,1.3851949189662724,0.8822811080704044,['FST'],0.8882122298600899,0,0,1
237,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5289102976805058,1.3851949189662724,0.8822811080704044,['LEF1'],0.8882122298600899,0,0,1
238,Gastrin signaling pathway WP4659,0.5488149163658063,1.0182738881549978,0.6109582466424576,"['EGR1', 'CDKN1A', 'PRKCH', 'KLF4', 'CD44']",0.9021893188926763,0,0,5
239,Cancer immunotherapy by PD-1 blockade WP4585,0.5505701935346202,1.2985381077529565,0.7749686104384114,['NFATC1'],0.9021893188926763,0,0,1
240,Canonical and non-canonical TGF-B signaling WP3874,0.5505701935346202,1.2985381077529565,0.7749686104384114,['LOXL1'],0.9021893188926763,0,0,1
241,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5505701935346202,1.2985381077529565,0.7749686104384114,['TLR4'],0.9021893188926763,0,0,1
242,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5505701935346202,1.2985381077529565,0.7749686104384114,['CDKN1A'],0.9021893188926763,0,0,1
243,Neural Crest Differentiation WP2064,0.5523410474371307,1.0258314603081533,0.6089228697059077,"['NOTCH3', 'MIA', 'ZIC5', 'TBX6']",0.9021893188926763,0,0,4
244,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5542353155879436,1.0934210526315788,0.6452998469842777,"['CYCS', 'ACTG1']",0.9021893188926763,0,0,2
245,Osteoblast differentiation WP4787,0.5571589676288461,1.0083236074950943,0.5897731970599132,"['NOTCH3', 'PRKCH', 'GLI3', 'FGF10', 'GLI2']",0.9021893188926763,0,0,5
246,Endometrial cancer WP4155,0.5578713166622029,1.03866930171278,0.6061954054431808,"['CDKN1A', 'GADD45B', 'LEF1']",0.9021893188926763,0,0,3
247,IL-6 signaling pathway WP364,0.5677389666866104,1.0653171390013496,0.6030691414766347,"['SOCS3', 'VIP']",0.9021893188926763,0,0,2
248,Apoptosis Modulation by HSP70 WP384,0.5712354481431016,1.2220762155059133,0.6843062339707089,['CYCS'],0.9021893188926763,0,0,1
249,Nanomaterial induced apoptosis WP2507,0.5712354481431016,1.2220762155059133,0.6843062339707089,['CYCS'],0.9021893188926763,0,0,1
250,Nicotine Activity on Dopaminergic Neurons WP1602,0.5712354481431016,1.2220762155059133,0.6843062339707089,['SLC18A2'],0.9021893188926763,0,0,1
251,Nucleotide metabolism WP404,0.5712354481431016,1.2220762155059133,0.6843062339707089,['OAZ1'],0.9021893188926763,0,0,1
252,Transcription co-factors SKI and SKIL protein partners WP4533,0.5712354481431016,1.2220762155059133,0.6843062339707089,['TEAD2'],0.9021893188926763,0,0,1
253,Melanoma WP4685,0.5792494238346408,1.0050363381359173,0.5487720623222979,"['CDKN1A', 'GADD45B', 'CALM3']",0.9102988965561828,0,0,3
254,Eukaryotic Transcription Initiation WP405,0.58094452192279,1.0386184210526315,0.5640736789245375,"['POLR2I', 'POLR2K']",0.9102988965561828,0,0,2
255,"GPCRs, Other WP117",0.5896909106580398,0.9890206411945542,0.5223579370270529,"['ADGRV1', 'OR10A2', 'GPR18']",0.9125584366190819,0,0,3
256,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5909516789120384,1.154110089064097,0.6070861737306382,['EGR1'],0.9125584366190819,0,0,1
257,Transcription factor regulation in adipogenesis WP3599,0.5909516789120384,1.154110089064097,0.6070861737306382,['LEP'],0.9125584366190819,0,0,1
258,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5938508419204578,1.0132220795892168,0.5280174830098486,"['TEAD2', 'ACTG1']",0.9125584366190819,0,0,2
259,Prostaglandin Synthesis and Regulation WP98,0.5938508419204578,1.0132220795892168,0.5280174830098486,"['HSD11B2', 'ANXA3']",0.9125584366190819,0,0,2
260,MECP2 and Associated Rett Syndrome WP3584,0.599964065203298,0.9735054347826086,0.497349827241591,"['BDNF', 'SST', 'FKBP5']",0.914887731612692,0,0,3
261,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.599964065203298,0.9735054347826086,0.497349827241591,"['YAP1', 'TIE1', 'ANGPTL1']",0.914887731612692,0,0,3
262,Regulation of Microtubule Cytoskeleton WP2038,0.6064575198189299,0.9890350877192983,0.4946368161204892,"['PARD6A', 'RHO']",0.9192630328417342,0,0,2
263,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6097624137442659,1.0932982917214191,0.5408392312043382,['LDHA'],0.9192630328417342,0,0,1
264,Vitamin D in inflammatory diseases WP4482,0.6097624137442659,1.0932982917214191,0.5408392312043382,['NFATC1'],0.9192630328417342,0,0,1
265,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.618764816690497,0.9659730722154223,0.4636960724210713,"['ADCY10', 'ADCY4']",0.9231762170906129,0,0,2
266,Regulatory circuits of the STAT3 signaling pathway WP4538,0.619997596161858,0.9438854952688944,0.45121471832991655,"['SOCS3', 'DUSP2', 'OSMR']",0.9231762170906129,0,0,3
267,Small cell lung cancer WP4658,0.6238354234172819,0.9331475497317008,0.44032311179675476,"['CDKN1A', 'GADD45B', 'LAMB2', 'CYCS']",0.9231762170906129,0,0,4
268,miRNA targets in ECM and membrane receptors WP2911,0.6277091867336403,1.0385676741130092,0.48363842706464666,['LAMB2'],0.9231762170906129,0,0,1
269,Purine metabolism and related disorders WP4224,0.6277091867336403,1.0385676741130092,0.48363842706464666,['XDH'],0.9231762170906129,0,0,1
270,Urea cycle and metabolism of amino groups WP497,0.6277091867336403,1.0385676741130092,0.48363842706464666,['CKM'],0.9231762170906129,0,0,1
271,Senescence and Autophagy in Cancer WP615,0.6322468830972812,0.9227206097918499,0.4230446298919323,"['CDKN1A', 'IL1B', 'CXCL1', 'CD44']",0.9231762170906129,0,0,4
272,Cell cycle WP179,0.6360392656565053,0.9185069148127798,0.4156197672160228,"['CDKN1A', 'GADD45B', 'SFN', 'CDC14A', 'YWHAH']",0.9231762170906129,0,0,5
273,Non-small cell lung cancer WP4255,0.6393376613721737,0.91600790513834,0.4097509851841289,"['CDKN1A', 'GADD45B', 'CYCS']",0.9231762170906129,0,0,3
274,Exercise-induced Circadian Regulation WP410,0.6424852929496094,0.9229239766081871,0.40831204504636687,"['PER2', 'CLDN5']",0.9231762170906129,0,0,2
275,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6448316290230914,0.9890494962768287,0.4339613274208783,['LEF1'],0.9231762170906129,0,0,1
276,Fatty Acid Biosynthesis WP357,0.6448316290230914,0.9890494962768287,0.4339613274208783,['ACACB'],0.9231762170906129,0,0,1
277,Hippo-Yap signaling pathway WP4537,0.6448316290230914,0.9890494962768287,0.4339613274208783,['TEAD2'],0.9231762170906129,0,0,1
278,NAD+ biosynthetic pathways WP3645,0.6448316290230914,0.9890494962768287,0.4339613274208783,['ACMSD'],0.9231762170906129,0,0,1
279,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6539018110057718,0.9028032036613273,0.3835090629047695,"['ARC', 'BDNF']",0.9255935206613661,0,0,2
280,Constitutive Androstane Receptor Pathway WP2875,0.6611675562966961,0.9440329709712101,0.3905917368233236,['CYP3A5'],0.9255935206613661,0,0,1
281,DNA Mismatch Repair WP531,0.6611675562966961,0.9440329709712101,0.3905917368233236,['POLE3'],0.9255935206613661,0,0,1
282,RAS and bradykinin pathways in COVID-19 WP4969,0.6611675562966961,0.9440329709712101,0.3905917368233236,['IL1B'],0.9255935206613661,0,0,1
283,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6611675562966961,0.9440329709712101,0.3905917368233236,['PLA1A'],0.9255935206613661,0,0,1
284,7q11.23 copy number variation syndrome WP4932,0.664662862238014,0.883231347891989,0.36077822597609277,"['CLDN5', 'ATP5MC3', 'ACACB', 'ATP5MC1']",0.9255935206613661,0,0,4
285,Prolactin Signaling Pathway WP2037,0.6670321061982185,0.8771363358013695,0.35516750051602575,"['SOCS3', 'CISH', 'PRLR']",0.9255935206613661,0,0,3
286,IL-4 signaling pathway WP395,0.6758592067082736,0.8650767543859649,0.3389115515067496,"['SOCS3', 'IL4R']",0.9255935206613661,0,0,2
287,Angiogenesis WP1539,0.676753051538838,0.9029309261269497,0.3525483339613714,['FLT1'],0.9255935206613661,0,0,1
288,Gastric Cancer Network 1 WP2361,0.676753051538838,0.9029309261269497,0.3525483339613714,['GATD3A'],0.9255935206613661,0,0,1
289,miRNA regulation of p53 pathway in prostate cancer WP3982,0.676753051538838,0.9029309261269497,0.3525483339613714,['PMAIP1'],0.9255935206613661,0,0,1
290,MTHFR deficiency WP4288,0.676753051538838,0.9029309261269497,0.3525483339613714,['CYCS'],0.9255935206613661,0,0,1
291,Pregnane X receptor pathway WP2876,0.676753051538838,0.9029309261269497,0.3525483339613714,['CYP3A5'],0.9255935206613661,0,0,1
292,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6846145654217276,0.8529969137473604,0.32319991415729143,"['LEF1', 'KLF4', 'DKK1']",0.933104314273006,0,0,3
293,PI3K-Akt signaling pathway WP4172,0.6903068219659411,0.891641577060932,0.3304594083634242,"['CDKN1A', 'IL4R', 'FLT1', 'VWF', 'PKN3', 'BDNF', 'LAMB2', 'OSMR', 'TLR4', 'PRLR', 'TLR2', 'FGF10']",0.933104314273006,0,0,12
294,EPO Receptor Signaling WP581,0.6916225444988361,0.8652540516863776,0.3190320854611462,['CISH'],0.933104314273006,0,0,1
295,Photodynamic therapy-induced unfolded protein response WP3613,0.6916225444988361,0.8652540516863776,0.3190320854611462,['DNAJB9'],0.933104314273006,0,0,1
296,RANKL/RANK signaling pathway WP2018,0.6966693500793473,0.8303684210526315,0.3001319915711238,"['VCAM1', 'NFATC1']",0.9353393263820445,0,0,2
297,7-oxo-C and 7beta-HC pathways WP5064,0.7058088871752703,0.8305913272010512,0.28938696900368666,['HSD11B2'],0.9353393263820445,0,0,1
298,Ethanol effects on histone modifications WP3996,0.7058088871752703,0.8305913272010512,0.28938696900368666,['ADH1B'],0.9353393263820445,0,0,1
299,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7058088871752703,0.8305913272010512,0.28938696900368666,['CDKN1A'],0.9353393263820445,0,0,1
300,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7066530194993458,0.8140350877192982,0.28264560993114335,"['CDKN1A', 'LEF1']",0.9353393263820445,0,0,2
301,Ciliopathies WP4803,0.709549005717478,0.8539072847682119,0.29299754676618484,"['EVC2', 'DNAH11', 'RSPH4A', 'ZIC2', 'CCDC65', 'GLI3', 'GLI2']",0.9353393263820445,0,0,7
302,Ectoderm Differentiation WP2858,0.7120799394315566,0.8364405335151489,0.284026012896851,"['STC1', 'CCL2', 'NFATC1', 'GLI3', 'LY6E']",0.9353393263820445,0,0,5
303,TGF-beta Signaling Pathway WP366,0.7120799394315566,0.8364405335151489,0.284026012896851,"['YAP1', 'CDKN1A', 'PARD6A', 'CITED1', 'TGFB1I1']",0.9353393263820445,0,0,5
304,Lipid Metabolism Pathway WP3965,0.7193434262852716,0.7985949661376731,0.2630702715760282,['HILPDA'],0.9417719857287437,0,0,1
305,DNA damage response (only ATM dependent) WP710,0.7234660319723966,0.8135444151275286,0.2633456968615514,"['CDKN1A', 'MLKL', 'LEF1', 'PMAIP1']",0.9440111687390378,0,0,4
306,Genotoxicity pathway WP4286,0.7257975317440843,0.7832174776564051,0.25100881496321575,"['CDKN1A', 'RPS27']",0.9440111687390378,0,0,2
307,16p11.2 distal deletion syndrome WP4950,0.7322560717847679,0.7689687058938044,0.23962987401433317,['PLN'],0.9462270018517455,0,0,1
308,IL17 signaling pathway WP2112,0.7322560717847679,0.7689687058938044,0.23962987401433317,['IL17RB'],0.9462270018517455,0,0,1
309,Pyrimidine metabolism WP4022,0.7406648879003443,0.7780138339920949,0.2335651983052282,"['POLE3', 'POLR2I', 'POLR2K']",0.9530437461259508,0,0,3
310,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7525233499669023,0.7411184210526316,0.21071720032017874,"['SCIN', 'GLI3']",0.9530437461259508,0,0,2
311,Endochondral Ossification WP474,0.7525233499669023,0.7411184210526316,0.21071720032017874,"['SCIN', 'GLI3']",0.9530437461259508,0,0,2
312,Androgen receptor signaling pathway WP138,0.7551469709993968,0.7589414826954594,0.2131433156239704,"['CDKN1A', 'TGFB1I1', 'ETV5']",0.9530437461259508,0,0,3
313,Pancreatic adenocarcinoma pathway WP4263,0.7551469709993968,0.7589414826954594,0.2131433156239704,"['CDKN1A', 'GADD45B', 'DUSP6']",0.9530437461259508,0,0,3
314,Endothelin Pathways WP2197,0.7563285313117117,0.7158457564910055,0.19992099625208395,['ADCY10'],0.9530437461259508,0,0,1
315,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7563285313117117,0.7158457564910055,0.19992099625208395,['ADAMTS2'],0.9530437461259508,0,0,1
316,MAPK Signaling Pathway WP382,0.7572772242473084,0.8250713958325988,0.2293911994498096,"['DUSP4', 'NR4A1', 'DUSP2', 'BDNF', 'IL1R2', 'IL1B', 'NFATC1', 'DUSP6', 'FGF10']",0.9530437461259508,0,0,9
317,Fluoropyrimidine Activity WP1601,0.7675415595716248,0.691940429259746,0.18306159478880157,['ABCG2'],0.9530437461259508,0,0,1
318,miRNA regulation of prostate cancer signaling pathways WP3981,0.7675415595716248,0.691940429259746,0.18306159478880157,['CDKN1A'],0.9530437461259508,0,0,1
319,Prion disease pathway WP3995,0.7675415595716248,0.691940429259746,0.18306159478880157,['EBF1'],0.9530437461259508,0,0,1
320,TNF-alpha signaling pathway WP231,0.7756402040761775,0.7320158102766798,0.18598071013219045,"['CCL2', 'TNFRSF1B', 'SELE']",0.9530437461259508,0,0,3
321,Allograft Rejection WP2328,0.7769738461926102,0.7033006244424621,0.17747692033675722,"['HLA-DRB5', 'IL1B']",0.9530437461259508,0,0,2
322,Alpha 6 Beta 4 signaling pathway WP244,0.7782392399269699,0.6695773812046967,0.167877308614682,['LAMB2'],0.9530437461259508,0,0,1
323,Fatty acid beta-oxidation WP143,0.7782392399269699,0.6695773812046967,0.167877308614682,['TPI1'],0.9530437461259508,0,0,1
324,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7782392399269699,0.6695773812046967,0.167877308614682,['NFATC1'],0.9530437461259508,0,0,1
325,Melatonin metabolism and effects WP3298,0.7782392399269699,0.6695773812046967,0.167877308614682,['PER2'],0.9530437461259508,0,0,1
326,Disruption of postsynaptic signaling by CNV WP4875,0.7884452278629377,0.648612023653088,0.1541701088136042,['ARC'],0.9596366993561138,0,0,1
327,The influence of laminopathies on Wnt signaling WP4844,0.7884452278629377,0.648612023653088,0.1541701088136042,['LEF1'],0.9596366993561138,0,0,1
328,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7916441354170658,0.7509141730323742,0.17544607449937158,"['EGR1', 'EGR2', 'RAB3A', 'BDNF', 'ACACB']",0.9605925789511957,0,0,5
329,NRF2 pathway WP2884,0.79674956647519,0.7273526824978013,0.1652653450533824,"['EGR1', 'HMOX1', 'SLC7A11', 'SLC39A12']",0.9638490196265217,0,0,4
330,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7992842503715117,0.6691426146010186,0.1499138005524363,"['EGR1', 'CGA']",0.9639852474177626,0,0,2
331,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8074713757976916,0.6103810775295664,0.1305285727324436,['IFITM2'],0.9709172434062877,0,0,1
332,Oxysterols derived from cholesterol WP4545,0.8163336208531198,0.5929040735873851,0.12031930343020918,['CYP39A1'],0.9753198528988376,0,0,1
333,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8163336208531198,0.5929040735873851,0.12031930343020918,['CALM3'],0.9753198528988376,0,0,1
334,Wnt signaling pathway and pluripotency WP399,0.8234640051080814,0.6687067023672915,0.12988654054107887,"['PRKCH', 'LEF1', 'CD44']",0.9753198528988376,0,0,3
335,Bladder cancer WP2828,0.824788436162383,0.5763980143086582,0.11103060797857668,['CDKN1A'],0.9753198528988376,0,0,1
336,Vitamin D-sensitive calcium signaling in depression WP4698,0.824788436162383,0.5763980143086582,0.11103060797857668,['PVALB'],0.9753198528988376,0,0,1
337,16p11.2 proximal deletion syndrome WP4949,0.8320905280794065,0.6190102120974077,0.11378276559178849,"['TBX6', 'ALDOA']",0.9753198528988376,0,0,2
338,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8328545292513202,0.5607841744504031,0.10256534321329586,['PRKCH'],0.9753198528988376,0,0,1
339,Neural Crest Cell Migration during Development WP4564,0.8328545292513202,0.5607841744504031,0.10256534321329586,['BDNF'],0.9753198528988376,0,0,1
340,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8380415641928132,0.6098684210526316,0.10775617571147136,"['LEF1', 'ACTG1']",0.9753198528988376,0,0,2
341,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8405497495919141,0.5459921156373193,0.09483835952045652,['CCL2'],0.9753198528988376,0,0,1
342,ATM Signaling Pathway WP2516,0.847891128399492,0.5319586239428552,0.08777478890991147,['CDKN1A'],0.9753198528988376,0,0,1
343,Common Pathways Underlying Drug Addiction WP2636,0.847891128399492,0.5319586239428552,0.08777478890991147,['ACTG1'],0.9753198528988376,0,0,1
344,Copper homeostasis WP3286,0.847891128399492,0.5319586239428552,0.08777478890991147,['SCO2'],0.9753198528988376,0,0,1
345,Glycogen Synthesis and Degradation WP500,0.847891128399492,0.5319586239428552,0.08777478890991147,['CALM3'],0.9753198528988376,0,0,1
346,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.847891128399492,0.5319586239428552,0.08777478890991147,['CISH'],0.9753198528988376,0,0,1
347,Aryl Hydrocarbon Receptor Netpath WP2586,0.8548949155260845,0.5186268068331144,0.08130861145118551,['CDKN1A'],0.9777246447683382,0,0,1
348,Neural Crest Cell Migration in Cancer WP4565,0.8548949155260845,0.5186268068331144,0.08130861145118551,['BDNF'],0.9777246447683382,0,0,1
349,Focal Adhesion WP306,0.8677884589066683,0.6822344322344323,0.09674582618685923,"['FGR', 'FLT1', 'VWF', 'LAMB2', 'MYL9', 'ACTG1']",0.9777974097828415,0,0,6
350,Integrated Cancer Pathway WP1971,0.8679510216934925,0.4938677179150241,0.06994154252402236,['CDKN1A'],0.9777974097828415,0,0,1
351,Interleukin-11 Signaling Pathway WP2332,0.8679510216934925,0.4938677179150241,0.06994154252402236,['SOCS3'],0.9777974097828415,0,0,1
352,Wnt signaling WP428,0.8707611794171769,0.6033999769753252,0.0835030330079728,"['LEF1', 'NFATC1', 'DKK1']",0.9777974097828415,0,0,3
353,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.874032248965618,0.4823518626042845,0.06494289291225339,['DHCR24'],0.9777974097828415,0,0,1
354,Notch Signaling WP268,0.874032248965618,0.4823518626042845,0.06494289291225339,['NOTCH3'],0.9777974097828415,0,0,1
355,Nucleotide Excision Repair WP4753,0.874032248965618,0.4823518626042845,0.06494289291225339,['POLE3'],0.9777974097828415,0,0,1
356,T-cell receptor (TCR) signaling pathway WP69,0.874612758499225,0.5527017543859649,0.07404769374787254,"['IL1B', 'NFATC1']",0.9777974097828415,0,0,2
357,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8798337645889572,0.4713594552622148,0.06034451839862078,['CDKN1A'],0.9781392131463827,0,0,1
358,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8798337645889572,0.4713594552622148,0.06034451839862078,['EIF4A2'],0.9781392131463827,0,0,1
359,Amino Acid metabolism WP3925,0.8878246039053083,0.5313427800269905,0.06321973442991567,"['LDHA', 'PDK4']",0.9837446245509146,0,0,2
360,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8898192583877619,0.6992031872509961,0.0816228246759208,"['CDKN1A', 'IL4R', 'FLT1', 'VWF', 'LAMB2', 'HIF3A', 'OSMR', 'PRLR', 'FGF10']",0.9837446245509146,0,0,9
361,Glioblastoma signaling pathways WP2261,0.895902819616784,0.5179934210526316,0.05693956286796244,"['CDKN1A', 'PRKCH']",0.9869040507041902,0,0,2
362,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9034369703450787,0.5052952503209243,0.05131219353920864,"['LEF1', 'DKK1']",0.9869040507041902,0,0,2
363,Retinoblastoma gene in cancer WP2446,0.9034369703450787,0.5052952503209243,0.05131219353920864,"['CDKN1A', 'H2AFZ']",0.9869040507041902,0,0,2
364,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9050753228819834,0.4231274638633377,0.04220151000190169,['NDUFB11'],0.9869040507041902,0,0,1
365,Wnt Signaling Pathway WP363,0.9050753228819834,0.4231274638633377,0.04220151000190169,['LEF1'],0.9869040507041902,0,0,1
366,Translation Factors WP107,0.9094486927459737,0.41463863337713536,0.039356128786122255,['EIF4A2'],0.9881007782635712,0,0,1
367,Integrated breast cancer pathway WP1984,0.9131869527663691,0.5747214892993258,0.05219313193649311,"['RHO', 'FAU', 'SMAD6', 'TFPI']",0.9881007782635712,0,0,4
368,Interferon type I signaling pathways WP585,0.9136208201030005,0.40648269820411737,0.03672150519922444,['SOCS3'],0.9881007782635712,0,0,1
369,Modulators of TCR signaling and T cell activation WP5072,0.9213979172168063,0.3910941412738948,0.0320162519068084,['ELOB'],0.9896720747843795,0,0,1
370,G Protein Signaling Pathways WP35,0.9230921759125208,0.47066387559808615,0.037665433865969544,"['PRKCH', 'ADCY4']",0.9896720747843795,0,0,2
371,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9250201302004754,0.38382732272351194,0.029915416832980445,['YAP1'],0.9896720747843795,0,0,1
372,PPAR signaling pathway WP3942,0.9250201302004754,0.38382732272351194,0.029915416832980445,['UCP1'],0.9896720747843795,0,0,1
373,MET in type 1 papillary renal cell carcinoma WP4205,0.9317720655147892,0.37007227332457293,0.026151919212412923,['CDKN1A'],0.99156492533392,0,0,1
374,TYROBP causal network in microglia WP3945,0.9317720655147892,0.37007227332457293,0.026151919212412923,['TNFRSF1B'],0.99156492533392,0,0,1
375,Kit receptor signaling pathway WP304,0.9379166957091938,0.3572658480221125,0.022898648875315585,['TBX2'],0.9940423166065565,0,0,1
376,3q29 copy number variation syndrome WP4906,0.9435085795041035,0.3453131844064827,0.02007989984172964,['HAMP'],0.9940423166065565,0,0,1
377,G1 to S cell cycle control WP45,0.9461129402459858,0.3396307705564292,0.018813279319027116,['CDKN1A'],0.9940423166065565,0,0,1
378,AGE/RAGE pathway WP2324,0.9485973802292642,0.3341316603789581,0.01763240413388741,['CYCS'],0.9940423166065565,0,0,1
379,Pathways affected in adenoid cystic carcinoma WP3651,0.9485973802292642,0.3341316603789581,0.01763240413388741,['INSRR'],0.9940423166065565,0,0,1
380,Chemokine signaling pathway WP3929,0.9490856289208329,0.47358416558549316,0.024747734332105864,"['FGR', 'PARD3', 'ADCY4']",0.9940423166065565,0,0,3
381,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.955385069769049,0.3186495501870009,0.014543422095792038,['CASP1'],0.9962143247450107,0,0,1
382,ESC Pluripotency Pathways WP3931,0.957009939741592,0.4017373530914665,0.01765294239431063,"['SMAD6', 'FGF10']",0.9962143247450107,0,0,2
383,Male infertility WP4673,0.9586685587370328,0.3978491902834008,0.016793164655741277,"['CYP26B1', 'ETV5']",0.9962143247450107,0,0,2
384,Head and Neck Squamous Cell Carcinoma WP4674,0.9630634367998652,0.30010093507779617,0.011294597355241128,['CDKN1A'],0.9972478111767676,0,0,1
385,Fragile X Syndrome  WP4549,0.9732980625271017,0.35954233409610986,0.009730980976129816,"['ARC', 'BDNF']",0.9972478111767676,0,0,2
386,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9734619683158027,0.2723390275952694,0.00732497261765769,['CISH'],0.9972478111767676,0,0,1
387,DNA Repair Pathways Full Network WP4946,0.9753556038591032,0.35335132703553757,0.00881722957517225,"['FEN1', 'POLE3']",0.9972478111767676,0,0,2
388,DNA IR-damage and cellular response via ATR WP4016,0.975854679740475,0.26532228174803735,0.0064849003820089506,['FEN1'],0.9972478111767676,0,0,1
389,Insulin Signaling WP481,0.9774619709875021,0.4022637441609774,0.00916996096396148,"['SOCS3', 'EGR1', 'PRKCH']",0.9972478111767676,0,0,3
390,ErbB signaling pathway WP673,0.9842197074224033,0.2377392118658148,0.0037815100854808447,['CDKN1A'],0.9972478111767676,0,0,1
391,Ras signaling WP4223,0.9859997051347478,0.3706421149795271,0.0052257659922298125,"['FLT1', 'CALM3', 'PLA1A']",0.9972478111767676,0,0,3
392,Ciliary landscape WP4352,0.9888378495528627,0.3982001962958714,0.004469763253598782,"['YAP1', 'NEFL', 'COPS7A', 'NEFM']",0.9972478111767676,0,0,4
393,Integrin-mediated Cell Adhesion WP185,0.9891894942568368,0.2176084099868594,0.002365264981753333,['RHO'],0.9972478111767676,0,0,1
394,Regulation of Actin Cytoskeleton WP51,0.989508191816758,0.2991800152555301,0.0031555219970808334,"['ACTG1', 'FGF10']",0.9972478111767676,0,0,2
395,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9911029092390519,0.29067828020756115,0.002597764527496997,"['CLDN5', 'NOTCH3']",0.9972478111767676,0,0,2
396,Genes related to primary cilium development (based on CRISPR) WP4536,0.9922365156432161,0.20258431887866843,0.0015788970228812016,['EVC2'],0.9972478111767676,0,0,1
397,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9971262356159334,0.1677724004572503,0.0004828324551885296,['TRIP10'],0.9993969442745367,0,0,1
398,EGF/EGFR signaling pathway WP437,0.9993969442745367,0.1320041106506284,7.962984774436572e-05,['NEDD4'],0.9993969442745367,0,0,1
